News

Dear Chairman Pallone and Ranking Member Walden: On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your continued leadership on, and commitment to, bipartisan legislation that advances the public health and supports a safe, reliable, and affordable supply of critical medical products. HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs),...

Dear Chairman Alexander and Ranking Member Murray: On behalf of the Healthcare Supply Chain Association (HSCA), we applaud your leadership to promote U.S. public health preparedness and response. Through commitment to advancing recommendations to help prepare for the next pandemic, we can best work to provide critical support in emergencies facing this nation. The unprecedented nature of...

Dear Ambassador Lighthizer: On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on additional modifications of actions regarding Chinese exports under Section 301. HSCA is dedicated to supporting patient care and ensuring healthcare providers have access to critical medical supplies needed to...

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the U.S. Food and Drug Administration’s (FDA) request for comments and holding of workshop on a competitive marketplace for biosimilars. HSCA is committed to increasing competition and promoting innovation in the healthcare system, and we applaud FDA for collaborating with the U.S. Federal Trade Commission (FTC) to...

Washington, DC (March 24, 2020) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released its third annual report on the value that GPOs deliver to the healthcare system. The report, which was based on existing academic research and on a survey of HSCA member GPOs, found that GPOs deliver up to $34.1...

Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement in conjunction with the House Committee on Energy and Commerce’s open mark-up session on the Safeguarding Therapeutics Act and twelve other bills: “HSCA and its member group purchasing organizations (GPOs) applaud Representatives Engel, Guthrie,...

Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement in conjunction with “Confronting the Coronavirus: The Federal Response,” a hearing before the U.S. House Committee on Homeland Security: “HSCA and its member healthcare group purchasing organizations (GPOs) applaud members of the House Committee...

Dear Commissioner Hahn: On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding the importation of prescription drugs from Canada. HSCA is dedicated to ensuring patient access to affordable healthcare, and we applaud FDA for taking steps to reduce prescription drug costs, support...

Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement in conjunction with “An Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus,” a hearing before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP): “HSCA and its member healthcare group...

Dear Chairman Alexander and Ranking Member Murray, As the United States takes steps in response to the outbreak of COVID-19, concerns with the integrity of the drug supply chain and the potential impact on downstream drug shortages have surfaced. While no drug shortages have been reported thus far in direct correlation with COVID-19, past situations such as H1N1, Ebola, and Hurricane Maria...